¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÀü¸³¼±ÇÐȸ 2022 KPS-APSU Joint International Symposium(2ÀÏÂ÷) : 2022-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÀü¸³¼±ÇÐȸ 2022 KPS-APSU Joint International Symposium(2ÀÏÂ÷) : 2022-09-03
±³À°ÀÏÀÚ : 2022-09-03
±³À°Àå¼Ò : SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ 
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà) 2022 KPS-APSU Joint International Symposium(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÀü¸³¼±ÇÐȸ
´ã´çÀÚ : ¹èÁø¼º
¿¬¶ôó : 070-4336-5176  
À̸ÞÀÏ : gaonpco@gaonpco.com      
±³À°Á¾·ù : ºñ´¢ÀÇÇаú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í »çÀüµî·Ï - ±¹³»: 30000¿ø / ÇØ¿Ü: ¹«·áÇöÀåµî·Ï - ±¹³»: 40000¿ø / ÇØ¿Ü: ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ09:00~09:30 Inherited Kidney Cancer Syndromes  Brian M. SHUCH(UCLA USA) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ09:30~09:40 Evolving landscape of the Systemic Treatment for Metastatic Clear Cell RCC in the Era of Immunotherapy  ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ09:40~09:50 Role of Metastasectomy for Metastatic RCC: Update  ÃÖÁß¿ø(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ09:50~10:00 Treatment of Metastatic Non-Clear Cell RCC: Where Are We?  ±èÁ¤ÁØ(°¡Å縯ÀÇ´ë) 
Åä·Ð 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ10:00~10:15 Panel Discussion  Edmund CHIONG(National University of Singapore) 
È޽Ġ09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ10:15~10:30 Coffee Break  () 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ10:30~10:40 Salvage Robotic-Assisted Radical Prostatectomy after Focal or Whole Gland Therapy: Is it Feasible?  ÀÌÇйÎ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ10:40~10:50 BCR in 2022: What Test Can Be Done on Patients with Suspected BCR in the Era of Multi-Parametric MRI and PET-CT?  ÃÖÀç´ö(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ10:50~11:00 Extent of Pelvic Lymph Node Dissection during Radical Prostatectomy for Patients with Locally Advanced Prostate Cancer  ±è¿øÅÂ(ÃæºÏÀÇ´ë) 
Åä·Ð 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ11:00~11:15 Panel Discussion  Bannakij LOJANAPIWAT(Chiangmai University Thailand) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ11:15~11:30 KPS BLUE Award  () 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ11:30~12:00 The First Reimbursed Option for mHSPC All-comers, Enzalutamide  ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë) 
½Ä»ç 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ12:00~13:00 Lunch  () 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ13:00~13:30 Update the Advanced Prostate Cancer Consortium: Controversies and Consensus  Robert REITER(UCLA USA) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ13:30~13:40 Bipolar Androgen Therapy for Asymptomatic mCRPC: Myth or Reality?  ¼­¿øÀÍ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ13:40~13:50 Prevention of the Skeletal-Related Event with a Bone Protecting Agent for Patients with Bone Metastatic CRPC  ÃÖ¼¼¿µ(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ13:50~14:00 PSMA Beyond Imaging  ±èº´ÈÆ(ÀÎÁ¦ÀÇ´ë) 
Åä·Ð 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ14:00~14:15 Panel Discussion  ÀÌÇö¹«(¼º±Õ°üÀÇ´ë) 
È޽Ġ09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ14:15~14:30 Coffee Break  () 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ14:30~15:00 Contemporary Management of MIBC: Systemic Therapy, Radical Cystectomy, and Bladder Sparing  Seth LERNER(Baylor College of Medicine USA) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ15:00~15:15 The Role of Multi-Parametric MRI and VI-RADS for Local Staging of Muscle Invasive Bladder Cancer  ¹Ú°èÁø(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ15:15~15:25 Management of Distal Ureter during Nephroureterectomy for Upper Tract Urothelial Carcinoma  ¼Û¿Ï(¼º±Õ°üÀÇ´ë) 
Åä·Ð 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ15:25~15:35 Panel Discussion  Teng Aik ONG(University of Malaya) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ15:35~15:45 Recent Updates in Treatment for Metastatic Testicular Germ Cell Tumor  ÇÏÀ±¼®(°æºÏÀÇ´ë) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ15:45~15:55 Neoadjuvant Chemotherapy for Patients with Lymph Node-Positive Penile Cancer  ¹ÚÈ«ÁÖ(°­¿øÀÇ´ë) 
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ15:55~16:05 Do Newer Minimally Invasive Surgical Interventions for BPH Affect Sexual Function of Patients?  À̼ҿ¬(¸íÁöº´¿ø) 
Åä·Ð 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽǠ16:05~16:30 Panel Discussion  È«ÁØÇõ(¿ï»êÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÀü¸³¼±ÇÐȸ 2022 KPS-APSU Joint International Symposium(2ÀÏÂ÷) : 2022-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Àü³²´ëÇб³º´¿ø Á¦9ȸ ´ëÇѼҾÆÀ̺ñÀÎÈÄ°úÇÐȸ Áö¿ª¼øȸ¼¼¹Ì³ª : 2022-09-03
´ÙÀ½±Û 2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãß°èÇмú´ëȸ : 2022-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21030 ¼­¿ï Á¦31ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (2ÀÏÂ÷) - ¿Â/¿ÀÇÁ º´Çà : 2024-06-28 0 4 2024-06-18
21029 ´ë±¸ 2024 ´ëÇÑÀÀ±ÞÀÇÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-28 0 3 2024-06-18
21028 ¼­¿ï 2024 ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-06-28 0 7 2024-06-18
21027 ºÎ»ê ´ëÇѽÉÀåÇÐȸ ±âÃÊ°úÇבּ¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö 2024 : 2024-06-28 0 6 2024-06-18
21026 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾƳ»ºÐºñÇÐȸ ºñ¸¸¿¬±¸Áý´ãȸ 2024³â 1Â÷ : 2024-06-27 0 5 2024-06-18
21025 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ°øÁߺ¸°ÇÀÇ»çÇùÀÇȸ 3Â÷ ¿Â¶óÀÎ ÇÏ°è Çмú´ëȸ (1ÀÏÂ÷) : 2024-06-27 0 1 2024-06-18
21024 ºÎ»ê Á¦11Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Ãá°èÁ¾ÇÕ½ÉÆ÷Áö¾ö 1ÀÏÂ÷ : 2024-06-27 0 4 2024-06-18
21023 ´ë±¸ ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ ´ë±¸°æºÏÁöȸ 3Â÷ Áý´ãȸ : 2024-06-27 0 3 2024-06-18
21022 ¼­¿ï ´ëÇѼҾƸ¶ÃëÇÐȸ ¿Â¶óÀÎ 2024³â Èñ±Í³­Ä¡ Áúȯ ¸¶Ãë ÇÁ·ÎÅäÄÝ ¿þºñ³ª : 2024-06-27 0 5 2024-06-18
21021 ¼­¿ï (1ÀÏÂ÷)2024³â ´ëÇÑô¼öÇÐȸ 2nd ISCoS Regional Symposium : 2024-06-27 0 5 2024-06-18
21020 °­¿ø 2024 ö¿ø±ºÀÇ»çȸ 2Â÷ ¿¬¼ö°­ÁÂ_ÃÖ±Ù ÀÇÇÐÁö°ß(Ä¡¸Å, ¹é³»Àå°ú ³ë¾È) 0 6 2024-06-18
21019 ¼­¿ï Á¦31ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (1ÀÏÂ÷) - ¿Â/¿ÀÇÁ º´Çà : 2024-06-27 0 2 2024-06-18
21018 ÀüºÏ ±º»ê½ÃÀÇ»çȸ ¿¬¼ö±³À°(±â´É¼º ¼ÒÈ­ºÒ·®Áõ, º¸Çè½É»çÀÇ ÃֽŠÀ̽´) : 2024-06-27 0 3 2024-06-18
21017 ´ë±¸ 2024 ´ëÇÑÀÀ±ÞÀÇÇÐȸ Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-06-27 0 7 2024-06-18
21016 ºÎ»ê 2024 ±ÝÁ¤±¸ÀÇ»çȸ Çмú´ëȸ(¿¹¹æÁ¢Á¾, ÇʼöÀÇ·áÆÐÅ°Áö) : 2024-06-27 0 8 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷